Correlation Between Edesa Biotech and EnGene Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edesa Biotech and enGene Holdings Common, you can compare the effects of market volatilities on Edesa Biotech and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and EnGene Holdings.

Diversification Opportunities for Edesa Biotech and EnGene Holdings

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Edesa and EnGene is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and EnGene Holdings go up and down completely randomly.

Pair Corralation between Edesa Biotech and EnGene Holdings

Given the investment horizon of 90 days Edesa Biotech is expected to under-perform the EnGene Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Edesa Biotech is 1.04 times less risky than EnGene Holdings. The stock trades about -0.32 of its potential returns per unit of risk. The enGene Holdings Common is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  625.00  in enGene Holdings Common on August 26, 2024 and sell it today you would earn a total of  143.00  from holding enGene Holdings Common or generate 22.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Edesa Biotech  vs.  enGene Holdings Common

 Performance 
       Timeline  
Edesa Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edesa Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
enGene Holdings Common 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in enGene Holdings Common are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, EnGene Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.

Edesa Biotech and EnGene Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edesa Biotech and EnGene Holdings

The main advantage of trading using opposite Edesa Biotech and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.
The idea behind Edesa Biotech and enGene Holdings Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites